Resource Library

Search All Resources

  • Clear All
NASH Update 2024 | May 1, 2024

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #aasld  #fatty liver  #hepatitis  #liver  #MASLD  #nafl  #NAFLD  #NASH  #SLD  

In this presentation, Dr. Richard Manch, MD, provides a comprehensive overview and update as it relates to Steatotic Liver Disease (SLD) and particularly, Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD). Furthermore, Dr. Manch provides an American Association for the Study ...

Date added: 05/1/24

Evidence-Based Practices for Alcohol Use Disorder in Context of Cirrhosis | April 3, 2024

Type: Past Presentation  

Program: Hepatitis C  

Keywords: #alcohol  #aud  #medications  #pharmacotherapy  

In this presentation, Dr. Jasen Christensen, DO, discusses screening tools for alcohol use disorder (AUD), and ways to apply appropriate pharmacological treatments.  

Date added: 03/29/24

Syphilis Screening, Treatment and Management | March 27, 2024

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #sti  #syphilis  

In this presentation, Dr. Jorge Mera, MD, FACP, Indian Country ECHO Medical Director and Director of Infectious Diseases for Cherokee Nation Health Services (CNHS), shares how you and your staff can continue to recognize, stage, and treat syphilis.

Date added: 03/20/24

A National Initiative to Eliminate HCV in the United States | March 20, 2024

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #daa  #direct acting antiviral  #eliminate  #elimination  #hcv  #hep  #hepatitis  #hepc  #national  

In this presentation Dr. Karla Thornton provides an update on the national initiative to eliminate HCV in the United States, including a background on the epidemiology of the the public health crisis, current barriers to getting hepatitis C treatment, examples ...

Date added: 03/14/24

Medications for HCV in Pediatric Patients | March 6, 2024

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #children  #hcv  #hcv monitoring  #hcv testing  #hep c  #hepatitis  #pediatrics  #treatment  

In this presentation, Dr. Paulina Deming discusses the latest guidance on HCV screening in pediatrics, as well recommendations for monitoring and management. Then, Dr. Deming discusses the available HCV medications recommended for use in pediatric patients, helpful tools, dosing, formulations ...

Date added: 02/27/24

Substance Use Disorders: Habits, Triggers, Treatment | February 28, 2024

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #neurobiology  #sud diagnostic criteria  

In this presentation, Dr. Jessica Gregg, MD, PhD, reviews the terminology and definitions of substance use disorders. Then, Dr Gregg, discusses diagnostic criteria for substance use disorders, provides an overview of the neurobiology of addiction, and previews effective, evidence-based interventions.

Date added: 02/23/24

Long-Term Follow-Up After HCV Treatment | February 21, 2024

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #follow-up  #hcv  #hcv monitoring  #hcv testing  #hep c  #hepatitis  #treatment  

In this presentation, Dr. Paulina Deming discusses the needed follow-up for patients with and without cirrhosis who have completed HCV treatment.  

Date added: 02/20/24

Syringe Service Programs in Federal Facilities | February 7, 2024

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #federal  #harm reduction  #sup  #veterans health administration  

In this presentation, Beth Dinges, PharmD, Minh Q. Ho, DO, FIDSA, and Tessa Rife-Pennington, PharmD, BCGP, discuss expansion of harm reduction services and implementation of syringe services programs (SSP) within the Veterans Health Administration (VHA) and key lessons learned from ...

Date added: 02/1/24

Diabetes and HCV | January 24, 2024

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #diabetes  #dm  #hcc  #hcv and diabetes  #hepatitis c  #hepatocellular carcinoma  #type 2 diabetes  

In this presentation, Dr. Carol Greenlee, endocrinologist, discusses the relationship of diabetes, liver disease and HCV infection. Dr. Greenlee provides an overview of extra hepatic manifestations of HCV infection, HCV & insulin resistance, how HCV can potentially induce or aggravate ...

Date added: 01/20/24

Cirrhotic Ascites | January 17, 2024

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #ascites  #cirrhosis  #hcv  #management  #paracentesis  

In this presentation Richard Manch, MD, discusses management of patients with ascites. He discusses the indications and contraindications for paracentesis, initial laboratory investigation of ascitic fluid, the core elements for treatment of ascites (including sodium restriction, appropriate use of diuretics, ...

Date added: 01/17/24